Gold Standard:Pathological result
Sponsors
Yantai Yuhuangding Hospital, Department of Nuclear Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Guangdong Provincial People's Hospital, Department of Radiology, The Affiliated Hospital of Qingdao University, The Affiliated Hospital of Guizhou Medical University
Conditions
Bone TumorBreast CancerBreast cancerFocal liver lesionsNon-small cell lung cancerOvarian cancer, endometrial cancer, cervical cancerProstate cancer is a common cancer in men that originates in the prostate gland and often has no obvious symptoms in the early stages. As the disease progresses, urinary symptoms such as frequent urination, urgent need to urinate, and difficulty or pain during urination may occur, along with decreased sexual function, such as erectile dysfunction, as well as other symptoms like bone pain and weighsolid tumors
Early Phase 1
A multimodal integration system for early prediction of treatment response to neoadjuvant chemotherapy in patients with breast cancer: a multicenter,prospective study.
Active, not recruitingChiCTR2300076999
Start: 2023-11-01Updated: 2023-10-30
The predictive value of multimodal intergration system in predicting axillary lymph node response after neoadjuvant chemotherapy for breast cancer
Active, not recruitingChiCTR2300077197
Start: 2023-11-01Updated: 2023-11-06
The predictive value of multiregional DCE-MRI-based deep learning in predicting axillary lymph node response after neoadjuvant chemotherapy for breast cancer
Active, not recruitingChiCTR2400080446
Start: 2024-01-30Updated: 2024-02-05
Deep learning-based multi-task neoadjuvant chemotherapy treatment response prediction with whole slide images in breast cancer: a multicenter study
Active, not recruitingChiCTR2400080821
Start: 2024-02-10Updated: 2024-02-11
Deep learning based on multi-regional dynamic contrast-enhanced MRI to predict axillary lymph node response after neoadjuvant chemotherapy for breast cancer
Active, not recruitingChiCTR2400081165
Start: 2024-02-26Updated: 2024-03-04
A computer-aid breast cancer adjuvant diagnostic and prognostic prediction system based on deep learning-based multi-omics analysis
Active, not recruitingChiCTR2400081831
Start: 2024-04-01Updated: 2024-03-18
Research on generating recombined images based on CEM low-energy images.
Active, not recruitingChiCTR2400091510
Start: 2024-11-01Updated: 2024-11-04
Unknown Phase
Deep learning-enabled fully automated pipeline system for segmentation and classification of breast lesions using contrast enhanced mammography
Active, not recruitingChiCTR2200063444
Start: 2022-09-01Updated: 2023-04-17
Fluoride-labeled boronophenylalanine PET imaging in patients solid tumors
Active, not recruitingChiCTR2200063509
Start: 2022-09-09Updated: 2023-04-17
A two-stage artificial intelligence system based on deep learning assists radiologists to detect and classify breast lesions using Contrast Enhanced Mammography
Active, not recruitingChiCTR2200065169
Start: 2022-11-02Updated: 2023-05-15
Deep learning-based multi-task neoadjuvant chemotherapy treatment response prediction with multiscale WSI in breast cancer: a multicenter study (retrospect)
Active, not recruitingChiCTR2400084568
Start: 2024-05-23Updated: 2024-05-27
Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Based on Multi-Stain WSI Using Deep Learning: A Multicenter Study
Active, not recruitingChiCTR2400091648
Start: 2024-11-01Updated: 2024-11-04
Prospective Assessment of Bone Tumor Risk from Multimodal Multiview Radiography Images via Clinically Applicable Deep Learning
Active, not recruitingChiCTR2500102778
Start: 2025-06-01Updated: 2025-05-26
Research on constructing a predictive model for accurate non-invasive diagnosis of focal liver Lesions based on multimodal radiomics and deep learning
Active, not recruitingChiCTR2500104842
Start: 2025-07-01Updated: 2025-06-30
Multi omics analysis based on pathological genomics reveals heterogeneity phenotype and its correlation within tumors
Active, not recruitingChiCTR2500105628
Start: 2025-07-08Updated: 2025-07-14
Research on the Development of Early Diagnostic Markers for Gynecological Tumors Based on PhIP-Seq Technology
RecruitingChiCTR2500108639
Start: 2025-09-02Updated: 2025-09-08
Application of 18F-PSMA-1007 PET/CT in Patients with Newly Diagnosed and Recurrent Prostate Cancer
RecruitingChiCTR2500112856
Start: 2024-07-02Updated: 2025-11-24
The Enhanced Value of PET/CT Health Organ Radiomics in Predicting the Prognosis of Non Small Cell Lung Cancer
Active, not recruitingChiCTR2500114034
Start: 2025-12-05Updated: 2025-12-08